ScienceNow

ScienceNow is a biotechnology venture studio and research organization dedicated to the fields of longevity and personalized medicine. The company specializes in the analysis of high-dimensional biological data to quantify the aging process and identify novel targets for therapeutic intervention. ScienceNow is best known for incubating Gero, a leading AI-driven company focused on drug discovery for age-related chronic diseases. Through its diagnostic platforms and research collaborations, ScienceNow aims to bridge fundamental gerontology with clinical applications to extend human healthspan. The firm operates at the intersection of biology and data science, developing tools for biological age estimation and health risk assessment.